BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27743930)

  • 1. Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism.
    Modgil A; Parakala ML; Ackley MA; Doherty JJ; Moss SJ; Davies PA
    Neuropharmacology; 2017 Feb; 113(Pt A):314-322. PubMed ID: 27743930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABA
    Parakala ML; Zhang Y; Modgil A; Chadchankar J; Vien TN; Ackley MA; Doherty JJ; Davies PA; Moss SJ
    J Biol Chem; 2019 Aug; 294(32):12220-12230. PubMed ID: 31239352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3
    Chuang SH; Reddy DS
    J Pharmacol Exp Ther; 2018 Jun; 365(3):583-601. PubMed ID: 29602830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kindling alters neurosteroid-induced modulation of phasic and tonic GABAA receptor-mediated currents: role of phosphorylation.
    Kia A; Ribeiro F; Nelson R; Gavrilovici C; Ferguson SS; Poulter MO
    J Neurochem; 2011 Mar; 116(6):1043-56. PubMed ID: 21175618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroactive Steroids Reverse Tonic Inhibitory Deficits in Fragile X Syndrome Mouse Model.
    Modgil A; Vien TN; Ackley MA; Doherty JJ; Moss SJ; Davies PA
    Front Mol Neurosci; 2019; 12():15. PubMed ID: 30804752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C regulates tonic GABA(A) receptor-mediated inhibition in the hippocampus and thalamus.
    Bright DP; Smart TG
    Eur J Neurosci; 2013 Nov; 38(10):3408-23. PubMed ID: 24102973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of neurosteroid potentiation by protein kinases at synaptic- and extrasynaptic-type GABAA receptors.
    Adams JM; Thomas P; Smart TG
    Neuropharmacology; 2015 Jan; 88():63-73. PubMed ID: 25278033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors.
    Abramian AM; Comenencia-Ortiz E; Modgil A; Vien TN; Nakamura Y; Moore YE; Maguire JL; Terunuma M; Davies PA; Moss SJ
    Proc Natl Acad Sci U S A; 2014 May; 111(19):7132-7. PubMed ID: 24778259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-subunit-containing GABAA-receptors mediate tonic inhibition in paracapsular cells of the mouse amygdala.
    Marowsky A; Vogt KE
    Front Neural Circuits; 2014; 8():27. PubMed ID: 24723854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased surface expression of the δ subunit of the GABA
    Zhang N; Peng Z; Tong X; Lindemeyer AK; Cetina Y; Huang CS; Olsen RW; Otis TS; Houser CR
    Exp Neurol; 2017 Nov; 297():168-178. PubMed ID: 28822839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enduring changes in tonic GABAA receptor signaling in dentate granule cells after controlled cortical impact brain injury in mice.
    Boychuk JA; Butler CR; Halmos KC; Smith BN
    Exp Neurol; 2016 Mar; 277():178-189. PubMed ID: 26772635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing α4βδ GABAA receptor heterogeneity: differential regional effects of a functionally selective α4β1δ/α4β3δ receptor agonist on tonic and phasic inhibition in rat brain.
    Hoestgaard-Jensen K; Dalby NO; Krall J; Hammer H; Krogsgaard-Larsen P; Frølund B; Jensen AA
    J Neurosci; 2014 Dec; 34(49):16256-72. PubMed ID: 25471566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A1 Receptor Suppresses Tonic GABAA Receptor Currents in Hippocampal Pyramidal Cells and in a Defined Subpopulation of Interneurons.
    Rombo DM; Dias RB; Duarte ST; Ribeiro JA; Lamsa KP; Sebastião AM
    Cereb Cortex; 2016 Mar; 26(3):1081-95. PubMed ID: 25452570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic Expression of α6 and δ GABAA Receptor Subunits in Hilar Somatostatin Neurons Increases Tonic Inhibition and Alters Network Activity in the Dentate Gyrus.
    Tong X; Peng Z; Zhang N; Cetina Y; Huang CS; Wallner M; Otis TS; Houser CR
    J Neurosci; 2015 Dec; 35(49):16142-58. PubMed ID: 26658866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors.
    Stell BM; Brickley SG; Tang CY; Farrant M; Mody I
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14439-44. PubMed ID: 14623958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator.
    Martin BS; Martinez-Botella G; Loya CM; Salituro FG; Robichaud AJ; Huntsman MM; Ackley MA; Doherty JJ; Corbin JG
    J Neurosci Res; 2016 Jun; 94(6):568-78. PubMed ID: 26308557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrous cycle regulation of extrasynaptic δ-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis.
    Wu X; Gangisetty O; Carver CM; Reddy DS
    J Pharmacol Exp Ther; 2013 Jul; 346(1):146-60. PubMed ID: 23667248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etomidate blocks LTP and impairs learning but does not enhance tonic inhibition in mice carrying the N265M point mutation in the beta3 subunit of the GABA(A) receptor.
    Zarnowska ED; Rodgers FC; Oh I; Rau V; Lor C; Laha KT; Jurd R; Rudolph U; Eger EI; Pearce RA
    Neuropharmacology; 2015 Jun; 93():171-178. PubMed ID: 25680234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perimenstrual-like hormonal regulation of extrasynaptic δ-containing GABAA receptors mediating tonic inhibition and neurosteroid sensitivity.
    Carver CM; Wu X; Gangisetty O; Reddy DS
    J Neurosci; 2014 Oct; 34(43):14181-97. PubMed ID: 25339733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of extra-synaptic α5-GABA
    Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
    Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.